Blockchain Registration Transaction Record

Amerigo Scientific Launches Premium iPSC-Derived Cells for Research

Amerigo Scientific releases high-purity iPSC-derived cells and engineered reporter cells for disease research, drug screening, and cell therapy development. Explore over 10 cell types and reagents.

This news matters because iPSC-derived cells are revolutionizing biomedical research by providing ethical, reproducible, and patient-specific models for studying diseases and testing therapies. For researchers, these products offer easy access to high-quality cells that mimic human biology closely, enabling more accurate drug screening and disease modeling. For patients, this technology accelerates the development of personalized cell therapies and targeted treatments. The availability of standardized iPSC-derived cells from Amerigo Scientific lowers barriers for labs worldwide, fostering innovation in regenerative medicine and precision medicine.